nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—CA5A—Reversible hydration of carbon dioxide—CA7—colon cancer	0.314	0.334	CbGpPWpGaD
Dobutamine—CA5B—Reversible hydration of carbon dioxide—CA7—colon cancer	0.293	0.312	CbGpPWpGaD
Dobutamine—CA2—Reversible hydration of carbon dioxide—CA7—colon cancer	0.208	0.221	CbGpPWpGaD
Dobutamine—COMT—Metapathway biotransformation—CHST4—colon cancer	0.0269	0.0286	CbGpPWpGaD
Dobutamine—COMT—Metapathway biotransformation—CHST5—colon cancer	0.0124	0.0131	CbGpPWpGaD
Dobutamine—CA5A—liver—colon cancer	0.00682	0.113	CbGeAlD
Dobutamine—CA5A—Metabolism—CA7—colon cancer	0.00638	0.00679	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CA7—colon cancer	0.00596	0.00634	CbGpPWpGaD
Dobutamine—CA2—gall bladder—colon cancer	0.00516	0.0858	CbGeAlD
Dobutamine—CA2—Metabolism—CA7—colon cancer	0.00422	0.00449	CbGpPWpGaD
Dobutamine—COMT—smooth muscle tissue—colon cancer	0.00414	0.0688	CbGeAlD
Dobutamine—COMT—renal system—colon cancer	0.00399	0.0662	CbGeAlD
Dobutamine—CA5A—Metabolism—ODC1—colon cancer	0.00387	0.00411	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CHST5—colon cancer	0.00387	0.00411	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ODC1—colon cancer	0.00361	0.00384	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CHST5—colon cancer	0.00361	0.00384	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CA7—colon cancer	0.00354	0.00376	CbGpPWpGaD
Dobutamine—CA2—embryo—colon cancer	0.00327	0.0544	CbGeAlD
Dobutamine—COMT—digestive system—colon cancer	0.00327	0.0543	CbGeAlD
Dobutamine—ADRB2—Arf6 trafficking events—CDH1—colon cancer	0.00321	0.00341	CbGpPWpGaD
Dobutamine—CA5B—vagina—colon cancer	0.00314	0.0521	CbGeAlD
Dobutamine—COMT—bone marrow—colon cancer	0.00301	0.0501	CbGeAlD
Dobutamine—COMT—vagina—colon cancer	0.00289	0.048	CbGeAlD
Dobutamine—ADRB2—Arf6 signaling events—SRC—colon cancer	0.00271	0.00288	CbGpPWpGaD
Dobutamine—CA2—epithelium—colon cancer	0.00267	0.0444	CbGeAlD
Dobutamine—CA2—smooth muscle tissue—colon cancer	0.00257	0.0428	CbGeAlD
Dobutamine—CA2—Metabolism—CHST5—colon cancer	0.00256	0.00272	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ODC1—colon cancer	0.00256	0.00272	CbGpPWpGaD
Dobutamine—CA2—renal system—colon cancer	0.00248	0.0412	CbGeAlD
Dobutamine—COMT—liver—colon cancer	0.00244	0.0405	CbGeAlD
Dobutamine—ADRB2—Arf6 signaling events—EGFR—colon cancer	0.00237	0.00253	CbGpPWpGaD
Dobutamine—ADRB2—Arf6 trafficking events—CTNNB1—colon cancer	0.00237	0.00252	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ODC1—colon cancer	0.00214	0.00228	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CHST5—colon cancer	0.00214	0.00228	CbGpPWpGaD
Dobutamine—CA2—lymphoid tissue—colon cancer	0.00206	0.0342	CbGeAlD
Dobutamine—CA2—digestive system—colon cancer	0.00203	0.0338	CbGeAlD
Dobutamine—CA5B—lymph node—colon cancer	0.00203	0.0337	CbGeAlD
Dobutamine—COMT—Transmission across Chemical Synapses—BRAF—colon cancer	0.00199	0.00212	CbGpPWpGaD
Dobutamine—CA2—bone marrow—colon cancer	0.00187	0.0311	CbGeAlD
Dobutamine—COMT—lymph node—colon cancer	0.00187	0.031	CbGeAlD
Dobutamine—CA2—vagina—colon cancer	0.00179	0.0298	CbGeAlD
Dobutamine—COMT—Neuronal System—BRAF—colon cancer	0.00152	0.00162	CbGpPWpGaD
Dobutamine—CA2—liver—colon cancer	0.00151	0.0252	CbGeAlD
Dobutamine—CA2—lymph node—colon cancer	0.00116	0.0193	CbGeAlD
Dobutamine—CA5A—Metabolism—ABCB1—colon cancer	0.00102	0.00109	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DLC1—colon cancer	0.00101	0.00107	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—TYMS—colon cancer	0.001	0.00107	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DLC1—colon cancer	0.000985	0.00105	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ABCB1—colon cancer	0.000954	0.00101	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LGR5—colon cancer	0.000947	0.00101	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—TYMS—colon cancer	0.000937	0.000997	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LGR5—colon cancer	0.000926	0.000986	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—HRAS—colon cancer	0.000914	0.000972	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PPARG—colon cancer	0.000711	0.000756	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—HRAS—colon cancer	0.0007	0.000745	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AXIN2—colon cancer	0.00068	0.000724	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ABCB1—colon cancer	0.000675	0.000719	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AXIN2—colon cancer	0.000665	0.000708	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PPARG—colon cancer	0.000663	0.000706	CbGpPWpGaD
Dobutamine—CA2—Metabolism—TYMS—colon cancer	0.000663	0.000706	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ABCB1—colon cancer	0.000566	0.000602	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PTGS2—colon cancer	0.000559	0.000595	CbGpPWpGaD
Dobutamine—COMT—Metabolism—TYMS—colon cancer	0.000556	0.000592	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PTGS2—colon cancer	0.000522	0.000555	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARG—colon cancer	0.00047	0.0005	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—EP300—colon cancer	0.000465	0.000495	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—EP300—colon cancer	0.000434	0.000462	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARG—colon cancer	0.000394	0.000419	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTGS2—colon cancer	0.00037	0.000393	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CA—colon cancer	0.000344	0.000366	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CA—colon cancer	0.000321	0.000342	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS2—colon cancer	0.00031	0.00033	CbGpPWpGaD
Dobutamine—CA2—Metabolism—EP300—colon cancer	0.000307	0.000327	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AKT1—colon cancer	0.000281	0.000299	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKT1—colon cancer	0.000262	0.000279	CbGpPWpGaD
Dobutamine—COMT—Metabolism—EP300—colon cancer	0.000258	0.000274	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CA—colon cancer	0.000227	0.000242	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGFR3—colon cancer	0.000196	0.000209	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGFR3—colon cancer	0.000192	0.000204	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CA—colon cancer	0.000191	0.000203	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKT1—colon cancer	0.000186	0.000198	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APC—colon cancer	0.00018	0.000192	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—NRAS—colon cancer	0.00018	0.000192	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APC—colon cancer	0.000176	0.000188	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—NRAS—colon cancer	0.000176	0.000188	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BRAF—colon cancer	0.00017	0.00018	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BRAF—colon cancer	0.000166	0.000176	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EGFR—colon cancer	0.000164	0.000175	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EGFR—colon cancer	0.000161	0.000171	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CA—colon cancer	0.000157	0.000167	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKT1—colon cancer	0.000156	0.000166	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—KRAS—colon cancer	0.000155	0.000165	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CA—colon cancer	0.000154	0.000163	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—KRAS—colon cancer	0.000152	0.000162	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CA—colon cancer	0.000143	0.000152	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CA—colon cancer	0.00014	0.000148	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HRAS—colon cancer	0.000132	0.00014	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HRAS—colon cancer	0.000129	0.000137	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT1—colon cancer	0.000128	0.000137	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP3—colon cancer	0.000127	0.000135	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT1—colon cancer	0.000126	0.000134	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP3—colon cancer	0.000124	0.000132	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCND1—colon cancer	0.000124	0.000132	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CTNNB1—colon cancer	0.000123	0.00013	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCND1—colon cancer	0.000121	0.000129	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CTNNB1—colon cancer	0.00012	0.000128	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDKN1A—colon cancer	0.00012	0.000127	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDKN1A—colon cancer	0.000117	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT1—colon cancer	0.000117	0.000124	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT1—colon cancer	0.000114	0.000121	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EP300—colon cancer	0.000114	0.000121	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EP300—colon cancer	0.000111	0.000119	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SRC—colon cancer	0.000111	0.000118	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SRC—colon cancer	0.000108	0.000115	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—colon cancer	0.000108	0.000115	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NRAS—colon cancer	0.000107	0.000113	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—colon cancer	0.000106	0.000112	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NRAS—colon cancer	0.000104	0.000111	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MYC—colon cancer	9.92e-05	0.000106	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TGFB1—colon cancer	9.9e-05	0.000105	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MYC—colon cancer	9.71e-05	0.000103	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EGFR—colon cancer	9.71e-05	0.000103	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TGFB1—colon cancer	9.69e-05	0.000103	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EGFR—colon cancer	9.5e-05	0.000101	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KRAS—colon cancer	9.17e-05	9.76e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KRAS—colon cancer	8.97e-05	9.55e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CA—colon cancer	8.43e-05	8.97e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CA—colon cancer	8.24e-05	8.77e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TP53—colon cancer	8.15e-05	8.67e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TP53—colon cancer	7.97e-05	8.48e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HRAS—colon cancer	7.8e-05	8.29e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HRAS—colon cancer	7.63e-05	8.11e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT1—colon cancer	6.88e-05	7.32e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT1—colon cancer	6.73e-05	7.16e-05	CbGpPWpGaD
